---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-000132"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2024-01-02T23:59:59+00:00"
generated_at: "2026-06-07T05:11:18.769151+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics director Erick Lucera resigns pending successor appointment

## Summary
- Erick Lucera resigned as director effective upon appointment of a new director.
- Resignation was not due to any disagreement with the company's operations or policies.
- No replacement director has been named as of the filing date.

## SEC filing metadata
- accession: 0001493152-24-000132
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2024-01-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315224000132/0001493152-24-000132-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315224000132/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-000132
- JSON: https://secwatch.observer/filing/0001493152-24-000132.json
- Plain text: https://secwatch.observer/filing/0001493152-24-000132.txt

## Key facts
- Executive change
  Erick Lucera resigned as director at Bone Biologics Corp.
  - Action: resigned
  - Role: director
  source text: On December 27, 2023 Erick Lucera resigned as a director of the Company, effective upon the appointment of a new director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1419554/000149315224000132/0001493152-24-000132-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.